Skip Viragh Center for Pancreatic Cancer | Johns Hopkins Kimmel Cancer Center

Skip Navigation

COVID-19: We are vaccinating patients ages 12+. Learn more:

Vaccines, Boosters & 3rd Doses | Testing | Patient Care | Visitor Guidelines | Coronavirus | Self-Checker | Email Alerts

Philips Respironics issued a recall for some CPAP and BiLevel PAP devices and mechanical ventilators. Learn more.

Our collaborative team of scientists, physicians and allied health workers specialize in translating science learned in the laboratory into exceptional clinical care. Our center is a world leader in the diagnosis and management of pancreatic cancer, leading all institutions in novel therapies, innovative clinical trials and in training the next generation of pancreatic cancer experts.

Precision Medicine

We understand that pancreatic cancer patients are looking for hope, and we believe precision medicine is that hope.
Clinical Trials

Clinical trials are how cancer science becomes cancer medicine. Our experts excel at this type of bench-to-bedside discovery, and it is what ensures continued progress against cancer.
Our Experts

Our internationally recognized program has the world’s leading experts. Everything that can be done for pancreatic cancer happens at the Johns Hopkins Kimmel Cancer Center.
Our Multidisciplinary Approach

Our Center is the model for multispecialty care and one of the first to bring all the experts together to offer patients a comprehensive consultation, diagnosis and treatment plan.
Pioneering Research

Our experts are uniquely positioned to make progress against pancreatic cancer because much of the science that inspired advances unfolded here.
News

For the latest news on pancreatic cancer treatment and research discoveries, read our news magazine Pancreatic Cancer Matters.

Request an appointment: 410.933.PANC (7262)

The Next Generation of Pancreatic Cancer Pioneers

Our Center attracts the most accomplished young investigators interested in pursuing a career in pancreatic cancer research and treatment. Training side-by-side with established investigators, our young investigators are helping advance the science and bring much needed new therapies to patients.

Our Young Investigators

Patient Story Pancreatic Cancer Prevention | Lana's Story

Lana Brandt had a strong family history of pancreatic cancer. After experiencing several bouts of pancreatitis, she learned that she carried a genetic mutation that increased her risk of pancreatic cancer. As a means of pancreatic cancer prevention, experts at Johns Hopkins removed her pancreas and spleen using a minimally invasive technique. They then performed an autoislet cell transplant to help her body continue to produce insulin after surgery.

Read Arnold's Story